| Literature DB >> 27645777 |
Limin Sun1, Man Bai1, Lujie Xiang1, Guishan Zhang1, Wei Ma1, Huaizhi Jiang1.
Abstract
The Qianhua Mutton Merino (QHMM) is a new sheep (Ovis aries) variety with better meat performance compared with the traditional local variety Small Tail Han (STH) sheep. We aimed to evaluate the transcriptome regulators associated with muscle growth and development between the QHMM and STH. We used RNA-Seq to obtain the transcriptome profiles of the longissimus muscle from the QHMM and STH. The results showed that 960 genes were differentially expressed (405 were up-regulated and 555 were down-regulated). Among these, 463 differently expressed genes (DEGs) were probably associated with muscle growth and development and were involved in biological processes such as skeletal muscle tissue development and muscle cell differentiation; molecular functions such as catalytic activity and oxidoreductase activity; cellular components such as mitochondrion and sarcoplasmic reticulum; and pathways such as metabolic pathways and citrate cycle. From the potential genes, a gene-act-network and co-expression-network closely related to muscle growth and development were identified and established. Finally, the expressions of nine genes were validated by real-time PCR. The results suggested that some DEGs, including MRFs, GXP1 and STAC3, play crucial roles in muscle growth and development processes. This genome-wide transcriptome analysis of QHMM and STH muscle is reported for the first time.Entities:
Mesh:
Year: 2016 PMID: 27645777 PMCID: PMC5028831 DOI: 10.1038/srep33586
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The QHMM sheep and the STH sheep.
(a) QHMM sheep; (b) STH sheep.
Carcass and meat quality traits in the QHMM and STH.
| Traits | Definitions of traits | QHMM (n = 30) | STH (n = 30) |
|---|---|---|---|
| Live weight (Kg) | Live weight before slaughter (fasting 24h) | 55.33 ± 1.36* | 45.15 ± 4.15 |
| Carcass weight (Kg) | Body weight removing the head, tail, limbs, internal organs and other parts of the weight after slaughter | 27.38 ± 0.84** | 17.27 ± 0.84 |
| Slaughter percentage (%) | Carcass weight/Live weight ratio | 50.08 ± 1.73** | 38.33 ± 1.92 |
| Net meat percentage (%) | Net meat weight/ live weight ratio | 39.40 ± 1.76* | 31.35 ± 1.88 |
| Loin eye muscle area (cm2) | Area of longissimus dorsiat 12th/13th rib | 18.85 ± 1.52* | 15.39 ± 1.05 |
| Tenderness (N) | Shear force of longissimus dorsiat | 32.08 ± 1.34 | 47.77 ± 1.52** |
| Water loss rate (%) | % of weight loss of longissimus dorsiat determinated by pressure method | 6.23 ± 1.06 | 14.11 ± 0.93** |
| Cooking percentage (%) | longissimus dorsiat determinated by cooking / longissimus dorsiat weight ratio | 62.38 ± 3.05** | 45.03 ± 1.35 |
| pH1 | pH value in longissimus dorsiat 45 min post mortem | 6.13 ± 0.09 | 6.23 ± 0.07 |
| pH24 | pH value in longissimus dorsiat 24 h post mortem | 5.44 ± 0.14 | 5.72 ± 0.04* |
**P < 0.01 and *P < 0.05.
Reads mapping summary.
| Statistics | QHMM A1 | QHMM A2 | QHMM A3 | STH B1 | STH B2 | STH B3 |
|---|---|---|---|---|---|---|
| All reads | 18,752,596 | 17,482,106 | 16,488,130 | 17,458,226 | 14,790,361 | 17,408,297 |
| Un Mapped reads | 1,415,576 | 1,531,813 | 1,302,393 | 1,334,282 | 1,156,221 | 1,371,310 |
| Mapped reads | 17,337,020 | 15,950,293 | 15,185,737 | 16,123,944 | 13,634,140 | 16,036,987 |
| Mapped Rate | 0.925 | 0.912 | 0.921 | 0.924 | 0.922 | 0.921 |
| Unique Mapped reads | 16,437,180 | 14,905,935 | 14,372,858 | 15,292,633 | 12,779,250 | 15,237,071 |
| Unique Mapped Rate | 0.877 | 0.853 | 0.872 | 0.876 | 0.864 | 0.875 |
| Repeat Mapped reads | 899,853 | 1,044,371 | 812,891 | 831,323 | 854,906 | 799,930 |
| Junction All Mapped reads | 7,829,834 | 6,856,974 | 6,700,137 | 6,846,232 | 5,638,984 | 7,226,780 |
| Junction Unique Mapped reads | 7,826,739 | 6,854,001 | 6,697,036 | 6,843,592 | 5,636,750 | 7,223,760 |
Figure 2Gene structure and distribution on the chromosome analysis of mapped reads in QHMM and STH sheep.
(a) Gene structure of mapped reads; (b) Chromosome distribution of mapped reads.
Figure 3The top 15 significant GO terms and pathways of the DEGs (STH vs. QHMM; P < 0.05).
(a) Significant GO terms for all DEGs; (b) Significant GO terms for up-regulated DEGs; (c) Significant GO terms for down-regulated DEGs; (d) Significant pathways.
Figure 4GO-trees and pathway-act-network analysis of DEGs.
(a) GO-trees analysis of DEGs; (b) Pathway-act-network analysis of DEGs. The arrow between two nodes represents an interaction target between GO-terms or pathways.
Differential mRNAs associated with muscle growth and development process by GO analysis.
| Gene symbol | Description | QHMM (normalized counts) | STH (normalized counts) | Log2FoldChange | FDR | Style (STH vs.QHMM) | Enriched biological process |
|---|---|---|---|---|---|---|---|
| BCL9L | B-cell CLL/lymphoma 9-like protein | 364.4 | 156.2 | −1.2 | 5.16E-03 | down | 7 |
| BTG1 | Protein BTG1 | 670.5 | 3228.5 | 2.3 | 9.08E-05 | up | 4,10 |
| CASQ1 | Calsequestrin | 45168.0 | 17353.3 | −1.4 | 5.41E-04 | down | 1,8 |
| CASQ2 | Calsequestrin | 620.4 | 248.1 | −1.3 | 1.90E-02 | down | 8 |
| CDH15 | Cadherin-15 | 122.5 | 263.7 | 1.1 | 1.66E-03 | up | 5 |
| CITED2 | Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 | 155.9 | 289.7 | 0.9 | 2.54E-02 | up | 7 |
| CSRP3 | cDNA, FLJ93801, Homo sapiens cysteine and glycine-rich protein 3 (cardiac LIMprotein) (CSRP3), mRNA | 4896.3 | 18425.4 | 2.0 | 4.61E-02 | up | 1,9 |
| FHOD3 | FH1/FH2 domain-containing protein 3 | 502.7 | 172.0 | −1.5 | 0 | down | 8,9 |
| FOXP1 | cDNA FLJ58267, highly similar to Forkhead box protein P1 | 233.3 | 382.1 | 0.7 | 2.45E-02 | up | 1,8 |
| GPX1 | Glutathione peroxidase | 1529.1 | 761.9 | −1.0 | 1.22E-06 | down | 3 |
| HEYL | cDNA FLJ52278, highly similar to Homo sapiens hairy/enhancer-of-split related with YRPW motif-like (HEYL), mRNA | 310.0 | 186.4 | −0.7 | 7.27E-05 | down | 7 |
| HLF | Hepatic leukemia factor | 76.3 | 31.7 | −1.3 | 1.02E-04 | down | 7 |
| ITGA7 | cDNA FLJ12486 fis, clone NT2RM2000566, highly similar to Integrin alpha-7 | 4307.8 | 1157.3 | −1.9 | 0 | down | 1 |
| KIAA1161 | KIAA1161 ortholog | 661.6 | 214.7 | −1.6 | 1.19E-06 | down | 3 |
| LMOD2 | cDNA FLJ50049, highly similar to Mus musculus leiomodin 2 (cardiac) (Lmod2), mRNA | 5623.4 | 12507.3 | 1.2 | 1.18E-08 | up | 9 |
| MAFF | Transcription factor MafF | 73.1 | 239.3 | 1.7 | 1.89E-03 | up | 7 |
| MYF6 | Myogenic factor 6 | 1688.6 | 4474.1 | 1.4 | 0 | up | 1,2,4,6,7,8,10 |
| MYH6 | myosin, heavy chain 6, cardiac muscle, alpha | 12787.7 | 4502.7 | −1.5 | 1.17E-10 | down | 8,9 |
| MYL2 | Myosin light chain 2 | 63933.5 | 23309.3 | −1.5 | 7.13E-12 | down | 9 |
| MYL6B | myosin, light chain 6B, alkali, smooth muscle and non-muscle | 12018.3 | 1654.6 | −2.9 | 3.77E-02 | down | 1 |
| MYLK3 | Myosin light chain kinase 3 | 265.8 | 94.1 | −1.5 | 6.03E-06 | down | 8,9 |
| MYOD1 | Myoblast determination protein 1 | 232.5 | 37.5 | −2.6 | 3.46E-06 | down | 1,2,3,4,6,7,8,10 |
| MYOG | Myogenin | 501.8 | 148.6 | −1.8 | 2.41E-04 | down | 1,2,3,4,6,7,8,10 |
| NEO1 | Neogenin homolog 1 (Chicken), isoform CRA_a | 390.1 | 178.1 | −1.1 | 2.90E-06 | down | 5 |
| OMYHCS | Myosin heavy chain slow | 225230.0 | 88659.7 | −1.3 | 3.66E-14 | down | 8,9 |
| PPP3CB | Serine/threonine-protein phosphatase | 1978.0 | 1122.0 | −0.8 | 3.85E-02 | down | 3 |
| RXRG | Retinoic acid receptor RXR-gamma | 1104.1 | 273.7 | −2.0 | 2.89E-06 | down | 1 |
| SETD3 | SET domain containing 3, isoform CRA_a | 1297.1 | 719.0 | −0.9 | 1.02E-04 | down | 5 |
| STAC3 | SH3 and cysteine rich domain 3, isoform CRA_a | 5060.1 | 2569.4 | −1.0 | 4.65E-03 | down | 3 |
| XIRP1 | xin actin-binding repeat containing 1 | 7518.7 | 37631.7 | 2.3 | 1.11E-06 | up | 8 |
Enriched biological process: 1. skeletal muscle tissue development; 2. positive regulation of skeletal muscle fiber development; 3. skeletal muscle fiber development; 4. positive regulation of myoblast differentiation; 5. positive regulation of muscle cell differentiation; 6. muscle cell fate commitment; 7. muscle cell differentiation; 8. sarcomere organization; 9. myofibril assemly; 10. myoblast differentiation.
Figure 5Gene-act-network analysis of DEGs.
Red nodes represent the up-regulated mRNAs while green nodes represent the down-regulated mRNAs. (a: activation; b: binding/ association; c: compound; (e: expression; ind: indirect effect; inh: inhibition; m: missing interaction; pho: phosphorylation; u: ubiquitination).
Figure 6Co-expression-network analysis of DEGs for QHMM and STH.
(a) Co-expression-network analysis of DEGs for QHMM. (b) Co-expression-network analysis of DEGs for STH. The solid lines represent the positive correlation while the dotted lines represent the negative correlation. The same color node represent the same tendency of gene expression, the node size represents the co-expression ability of gene, the greater the node size, the greater the k-core value.
Figure 7Real time PCR validation of DEGs in QHMM and STH, (a) RT-PCR analysis of 9 DEGs, the values were calculated by the 2−ΔΔCt method, *P < 0.05, **P < 0.01. (b) RNA-seq data, the values were calculated and normalized by EBSeq algorithm, the fold changes were more than 1.5 and FDR < 0.05.